AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Daito Pharmaceutical Co., Ltd.
  3. Financials
  4. Net income margin (%)

Daito Pharmaceutical Co., Ltd.【JP:4577】

Market cap
¥44.2B
P/E ratio
19.2x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndNet income margin (%) YoY (%)
May 31, 20253.8-46.38%
May 31, 20247-11.97%
May 31, 20238-25.68%
May 31, 202210.7+23.21%
May 31, 20218.7-0.58%
May 31, 20208.8+2.66%
May 31, 20198.5+11.95%
May 31, 20187.6+9.09%
May 31, 20177-0.90%
May 31, 20167.1+7.00%
May 31, 20156.6+31.88%
May 31, 20145-4.18%
May 31, 20135.2+23.29%
May 31, 20124.2

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)